Skip to main content
. 2023 Feb 23;14:1007624. doi: 10.3389/fimmu.2023.1007624

Figure 10.

Figure 10

In vitro validation of the targets using MTT assay and qPCR. (A) MTT assay to measure cell viability in PC12 cells after treatment with AU at 0 to 160 μM concentrations (In comparison with the control group, *P < 0.05, and ** P < 0.01). (B) MTT assay to measure PC12 cell proliferation after treatment with AU at 0 to 5 mM concentrations (In comparison with the control group, *P < 0.05, and ** P < 0.01). (C) Quantitative analysis of BTN3A2, AURKA, PLA2G7, ERAP2, CXCL10, MARCO, MAP-2, and βIII-tubulin gene expression in HFLS cells by real-time PCR (In comparison between two groups, *P < 0.05, and ** P < 0.01). (D) Quantitative analysis of BTN3A2, AURKA, PLA2G7, CXCL10, MARCO, MAP-2, and βIII-tubulin gene expression in PC12 cells by real-time PCR (In comparison between two groups, *P < 0.05, and ** P < 0.01).